SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001561743-21-000035
Filing Date
2021-05-11
Accepted
2021-05-11 16:10:08
Documents
16
Period of Report
2021-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kin-20210505.htm   iXBRL 8-K 41315
2 EX-99.1 prq12021.htm EX-99.1 26020
8 image1a.jpg GRAPHIC 55397
  Complete submission text file 0001561743-21-000035.txt   340989

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20210505.xsd EX-101.SCH 2565
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20210505_cal.xml EX-101.CAL 713
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20210505_def.xml EX-101.DEF 16701
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20210505_lab.xml EX-101.LAB 30978
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20210505_pre.xml EX-101.PRE 17384
9 EXTRACTED XBRL INSTANCE DOCUMENT kin-20210505_htm.xml XML 14129
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 21911364
SIC: 2834 Pharmaceutical Preparations